|6.68||-0.0900||-1.40%||Vol 2.20M||1Y Perf -24.15%|
|Apr 13th, 2021 14:56 DELAYED|
|- -||- -%|
|Target Price||7.67||Analyst Rating||Moderate Buy 2.00|
|Potential %||14.82||Finscreener Ranking||★★★★★ 63.48|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★★★ 69.79|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★★+ 68.18|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★★★ 54.64|
|Market Cap||1.32B||Earnings Rating||Buy|
|Price Range Ratio 52W %||20.99||Earnings Date||19th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||19th May 2021|
|Estimated EPS Next Report||-0.06|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||2.06M|
|Avg. Monthly Volume||2.23M|
|Avg. Quarterly Volume||2.27M|
Frontline Ltd. (NYSE: FRO) stock closed at 6.67 per share at the end of the most recent trading day (a -1.4% change compared to the prior day closing price) with a volume of 2.58M shares and market capitalization of 1.32B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Oil & Gas industry, Energy sector and employs 157 people. Frontline Ltd. CEO is .
The one-year performance of Frontline Ltd. stock is -24.15%, while year-to-date (YTD) performance is 7.4%. FRO stock has a five-year performance of -5.64%. Its 52-week range is between 5.28 and 11.95, which gives FRO stock a 52-week price range ratio of 20.99%
Frontline Ltd. currently has a PE ratio of 3.60, a price-to-book (PB) ratio of 0.93, a price-to-sale (PS) ratio of 1.65, a price to cashflow ratio of 2.50, a PEG ratio of 2.32, a ROA of 10.39%, a ROC of 16.67% and a ROE of 25.36%. The company’s profit margin is 30.05%, its EBITDA margin is 51.10%, and its revenue ttm is $809.37 Million , which makes it $4.09 revenue per share.
Of the last four earnings reports from Frontline Ltd., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Frontline Ltd.’s next earnings report date is 19th May 2021.
The consensus rating of Wall Street analysts for Frontline Ltd. is Moderate Buy (2), with a target price of $7.67, which is +14.82% compared to the current price. The earnings rating for Frontline Ltd. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Frontline Ltd. has a dividend yield of 29.54% with a dividend per share of $2.00 and a payout ratio of 62.00%.
Frontline Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.10, ATR14 : 0.32, CCI20 : -210.70, Chaikin Money Flow : -0.28, MACD : 0.08, Money Flow Index : 48.11, ROC : -12.58, RSI : 39.26, STOCH (14,3) : 3.49, STOCH RSI : 0.00, UO : 35.09, Williams %R : -96.51), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Frontline Ltd. in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.